Home
 News
 Web resources

 Tumours list
   Contribution



Projects

RARE UROLOGIC TUMOURS
   General information
   Urologic tumour list
     Contribution

RARE MELANOMA
   General information
   Rare melanoma list
     Contribution

RARE SKIN TUMOURS
   General information
   Skin tumor list
     Contribution

RARE BREAST CANCER

(GLS - italian project)
   Info generali
   Scheda dati

HINT-OUT
   General information
   Design
   System
   Objectives
   Registration
   Member area

 

partially supported by



News

10/12/2001 - On November 30th, in the hall of the S. Pio X Private Hospital of Milan, Italy, the

Numerous specialists, including epidemiologists, geneticists, pathologists, medical oncologists, surgeons and radiotherapists, discussed about the tumors whose incidence is only 2/100.000 per year: they, just because very rare, pose serious problems for the diagnosis and treatment and they often lack of the financial support for the research, the information and the professional training. Oncology was not the only main subject of the meeting; other important topics were covered: the problems the patients with this type of tumour have to face, the voluntary associations which operate to help these patients and their families and all the existing activities in support of the specialists who have to treat these diseases.The Congress was organised under the aegis of the WHO Collaborating Centre on Rare Tumors, which is located at the San Pio X Private Hospital and is directed by Dr. Claudio Clemente; one of the

News Archive

3/8/2001 WHY?
17/11/2001 W.H.O. Collaborating Centre for Cancer Control of Uncommon Tumours
18/12/2001 Post-meeting survey
3/12/2002 QUIZ
5/5/2002 Dear Colleagues,
29/01/2003 New publication on rare cancers !
28/07/2003 Thyroid Cancer Treatment Receives Orphan Drug Status
02/08/2003 Breast cancer in men
24/09/2003 GISTs: The revolution continues
28/10/2003 Lessons learned from the management of a rare genetic cancer.
17/11/2003 Successful photodynamic therapy for nonresectable cholangiocarcinoma.
07/01/2004 Gene associated with higher risk of melanoma in men
08/03/2004 Susceptibility to Common Adult Cancers in Retinoblastoma Survivors
29/03/2004 FDA Approves First Drug for mesothelioma
25/08/2004 Gene therapy cures malignant melanoma in mice
20/10/2004 FDA grants orphan drug status to two new anticancer drugs.
15/11/2004 New experimental drug for myeloproliferative disorder
20/01/2005 New leukemia treatment granted FDA orphan drug status.
28/02/2005 U.S. F.D.A. grants new orphan drug designation for a targeted therapeutic for head and neck cancer.
02/05/2005 Possible targets for a multiple myeloma vaccine
17/10/2005 Orphan drug troxacitabine approved for AML in EU
03/11/2005 FDA designes interleukin 21 as an orphan drug
01/12/2005 Zactima has received FDA orphan drug designation
25/01/2006 CETT Program for Rare Genetic Diseases
23/02/2006 New research studies of multiple myeloma